Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Primitive Neuroectodermal Tumor (PNET) of the kidney: a case report

  • Giorgio Pomara1Email author,
  • Francesco Cappello2,
  • Maria G Cuttano1,
  • Francesca Rappa2,
  • Girolamo Morelli1,
  • Pierantonio Mancini1 and
  • Cesare Selli1
BMC Cancer20044:3

DOI: 10.1186/1471-2407-4-3

Received: 13 September 2003

Accepted: 26 January 2004

Published: 26 January 2004

Abstract

Background

A case of Primitive Neuroectodermal Tumor (PNET) of the kidney in a 27-year-old woman is presented. Few cases are reported in the literature with a variable, nonspecific presentation and an aggressive behaviour. In our case, a radical nephrectomy with lymphadenectomy was performed and there was no residual or recurrent tumour at 24-month follow-up.

Methods

The surgical specimens were formalin-fixed and paraffin embedded. The sections were stained with routinary H&E. Immunohistochemistry was performed.

Results

The immunohistochemical evaluation revealed a diffuse CD99 positivity in the cytoplasm of the neoplastic cells. Pankeratin, cytokeratin AE1/AE3, vimentin, desmin, S100, cromogranin were negative. The clinical presentation and the macroscopic aspect, together with the histological pattern, the cytological characteristic and the cellular immunophenotype addressed the diagnosis towards primary PNET of kidney.

Conclusions

Since sometimes it is difficult to discriminate between PNET and Ewing's tumour, we reviewed the difficulties in differential diagnosis. These tumors have a common precursor but the stage of differentiation in which it is blocked is probably different. This could also explain their different biological behaviour and prognosis.

Keywords

Renal PNET Ewing's Sarcoma rhabdomyosarcoma tumor stem cells carcinogenesis

Background

The peripheral Primitive Neuroectodermal Tumor (PNET), firstly recognized by Arthur Purdy Stout in 1918, is a member of the family of "small round-cell tumors". Primitive renal localization is very rare. There are almost 50 cases reported in the literature, although it is difficult to estimate the exact number since often it has not been differentiated from Ewing's Sarcoma [113]. Renal PNET is more aggressive than in the other sites. It frequently arises during childhood or adolescence, having an aggressive clinical course towards metastatic disease and death. It often recurs locally and metastasises early to regional lymph nodes, lungs, liver, bone and bone marrow, resulting in a poor prognosis. The 5-year disease-free survival rate, for patients presenting well confined extra-skeletal PNET, is around 45–55% and cases with advanced disease at presentation have a median relapse-free survival of only 2 years [1].

Case presentation

A 27-year-old woman was referred because of a mild left flank pain and haematuria. Ultrasonography identified a left renal mass homogeneously hyperechogenic in comparison with renal parenchyma. CT scan showed a 11 mm × 8 mm × 6 mm tumor replacing the upper half of the left kidney with extension into the renal vein. Chest x-ray was negative. Pathological stage after radical nephrectomy was T3aN0Mx.

The surgical specimens were formalin-fixed and paraffin embedded. The sections were stained with routinary H&E. Immunohistochemistry was performed using avidin biotin complex technique and diaminobenzidine as chromogen. The antibodies used included CD99 (Dako, M3601), pankeratin (Dako, M0821), cytokeratin AE1/AE3 (Dako, M3515), vimentin (Dako, M7010), desmin (Dako, M0760), S100 (Dako, Z0311), and chromogranin A (Dako, M0869), at suggested dilution. We performed also appropriate routinely positive and negative controls.

The tumor was multilobular, grey, glistening, focally hemorrhagic, surrounded by a capsule and with a sharp demarcation from the uninvolved kidney. Histologically, the tumor consisted of small round cells with round nuclei and scant cytoplasm. It presented different patterns, with cohesive lobules or rosettes and perivascular pseudo-rosettes or, in some areas, spindle cellular elements (fig. 1).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2407-4-3/MediaObjects/12885_2003_Article_93_Fig1_HTML.jpg
Figure 1

H&E features of the tumour (original magnification 10×; inset 40 ×): sheets of monotonous cells infiltrating vessels (small arrow) even near the capsule (long arrow). Homer-Wright rosettes were common (inset).

The immunohistochemical evaluation revealed a diffuse CD99 positivity in the cytoplasm of the neoplastic cells (fig. 2); tumoral cells were also visible in the vascular lumens (fig. 3). By contrast, pankeratin, cytokeratin AE1/AE3, vimentin, desmin, S100, cromogranin were negative.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2407-4-3/MediaObjects/12885_2003_Article_93_Fig2_HTML.jpg
Figure 2

Immunoperoxidase for CD99 (10×) showed the tumor composed of small round cells with round nuclei and scant cytoplasm arranged in cohesive lobules. There are spindle cellular elements with diffuse CD99 cytoplasmic staining. Inset a (40×) shows Homer-Wright type rosettes positive for CD99.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2407-4-3/MediaObjects/12885_2003_Article_93_Fig3_HTML.jpg
Figure 3

Immunoperoxydase for CD99 (X25) revealed positive tumoral cells in the vascular lumens (arrow).

The clinical presentation and the macroscopic aspect, together with the histological pattern, the cytological characteristic and the cellular immunophenotype addressed the diagnosis towards primary PNET of kidney. A bone scan did not reveal positive areas. Eight cycles of chemotherapy with Vincristine, Ifosfamide and Adriamycin, four cycles of Ifosfamide and VP16 and eight sittings of local radiotherapy were sequentially performed. Follow-up examinations with CT and bone scan failed to show residual or recurrent tumor after 24 months.

Conclusions

Primitive Neuroectodermal Tumor of the kidney is a rare entity. The few cases reported revealed a variable presentation and an aggressive behaviour. The distinction from other primary malignancies of the kidneys is crucial for prognosis. The differential diagnosis includes extra-osseous Ewing's sarcoma, rhabdomyosarcoma, Wilm's tumor, carcinoid, neuroblastoma, clear cell sarcoma of the kidney, lymphoma, the small cell variant of osteosarcoma, desmoplastic small round cell tumor and nephroblastoma [5].

The Homer-Wright type rosettes, commonly scarce of number or less defined in extra skeletal Ewing's sarcoma (ES), are a typical histological feature for PNET and can address the diagnosis although they can be found also in neuroblastoma [5]. To better address the diagnosis, an immunohistochemical analysis is necessary. In our case the presence of MIC-2 gene products, known also as CD99, 12E7, E2, 013 and HBA71, suggested a PNET diagnosis. Primitive neuroectodermal tumors only immunorreactive to CD99, even if uncommon, are reported in the literature [13]. The reactivity to vimentin, NSE and S-100 may facilitate the diagnosis but is not patognomonic, while CD 99 positivity is nowadays a clue for the diagnosis. Moreover cytogenetic studies (not performed in our case) demonstrated that PNET and Ewing's sarcoma can both be associated to a translocation of the long arms of chromosome 11 and 22, t(11;22)(q22;q12) [5]. Despite their genetic and antigenic similarity, many authors currently recognize PNET and extra-skeletal Ewing's sarcoma of the kidney as separate entities. It is also important to keep separate renal PNET and malignant rhabdomyosarcoma tumor (MRT). Weeks et al reported 8 cases suggestive for PNET but mimicking MRT [14]. Although renal PNET and MRT show similar clinico-pathological features, the latter usually occurs in very young children, having a more aggressive prognosis.

Rodriguez et al postulated that these two renal neoplasms share a common undifferentiated precursor to explain their similarity and we agree with these Authors [12]. Indeed, the hypothesis that tumors arise from stem cells (SCs) as a consequence of a maturative arrest is now growing [15]. SCs are present in almost all tissues and may originate different cellular lineages by the multi-step process named "differentiation". The role of SCs in tumorigenesis was clearly demonstrated in a number of carcinogenic models showing that solid and haematopoietic cancers could arise from tissue-specific SCs [1619]. In agreement with Sell and Pierce, we retain that the degree of malignancy of a carcinoma depends by the stage in which SCs differentiation stopped during carcinogenesis [19]. In particular, since PNET, Ewing's tumour and MRT have a similar morphology, our hypothesis is that the mesenchimal stem precursor of these tumors is the same, but the stage of differentiation in which it is blocked is different. This could explain why sometimes it is difficult to discriminate between these tumors, notwithstanding they present a different biological behaviour.

Declarations

Acknowledgements

Written consent was obtained from the patient for publication of the patient's details

Authors’ Affiliations

(1)
Department of Surgery – Urology Section – S. Chiara Hospital, University of Pisa
(2)
Department of Experimental Medicine – Human Anatomy Section, University of Palermo

References

  1. Casella R, Moch H, Rochlitz C, et al: Metastatic primitive neuroectodermal tumor of the kidney in adults. Eur Urol. 2001, 39: 613-617. 10.1159/000052514.View ArticlePubMedGoogle Scholar
  2. Cuesta Alcala JA, Solchaga Martinez A, Caballero Martinez MC, et al: Primary neuroectodermal tumor (PNET)of the kidney:26 cases. Current status of its diagnosis and treatment. Arch Esp Urol. 2001, 54: 1081-1093.PubMedGoogle Scholar
  3. Dogra PN, Goel A, Kumar R, et al: Extra-osseous Ewing's Sarcoma of the kidney. Urol Int. 2002, 69: 150-152. 10.1159/000065566.View ArticlePubMedGoogle Scholar
  4. Friedrichs N, Vorreuther R, Poremba C, et al: Primitive neuroectodermal tumor in the differential diagnosis of malignant kidney tumors. Pathol Res Pract. 2002, 198: 563-569.View ArticlePubMedGoogle Scholar
  5. Gonsulen G, Ergin M, Paydas S, et al: Primitive neuroectodermal tumor of the kidney: a rare entity. Int Urol Nephrol. 2001, 33: 449-451. 10.1023/A:1019511205650.View ArticleGoogle Scholar
  6. Jimenez RE, Folpe AL, Lapham RL, et al: Primary Ewing's Sarcoma/Primitive neuroectodermal tumor of the kidney. A clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002, 26: 320-327. 10.1097/00000478-200203000-00005.View ArticlePubMedGoogle Scholar
  7. Karnes RJ, Gettman MT, Anderson PM, et al: Primitive neuroectodermal tumor (extraskeletal Ewing's Sarcoma) of the kidney with vena caval tumor thrombus. J Urol. 2000, 164: 772-10.1097/00005392-200009010-00036.View ArticlePubMedGoogle Scholar
  8. Kuroda M, Urano M, Abe M, et al: Primary primitive neuroectodermal tumor of the kidney. Pathol Int. 2000, 50: 967-972. 10.1046/j.1440-1827.2000.01147.x.View ArticlePubMedGoogle Scholar
  9. Lam JS, Hensle TW, et al: Organ-confined Primitive Neuroectodermal tumor arising from the kidney. J Pediatr Surger. 2003, 38: 619-621. 10.1053/jpsu.2003.50135.View ArticleGoogle Scholar
  10. Premalata CS, Gayathri DV, et al: Primitive Neuroectodermal tumor of the kidney. A report of two cases diagnosed by fine needle aspiration cytology. Acta Cytol. 2003, 47: 475-479.View ArticlePubMedGoogle Scholar
  11. Ranadive NU, Urmi C, Kumar M: Primary primitive neuroectodermal tumor (PNET) of the kidney: a case report. Arch Esp Urol. 1999, 52: 190-192.PubMedGoogle Scholar
  12. Rodriguez-Galindo C, Marina NM, Fletcher BD, et al: Is primitive neuroectodermal tumor of kidney a distinct entity?. Cancer. 1997, 79: 2243-2250. 10.1002/(SICI)1097-0142(19970601)79:11<2243::AID-CNCR24>3.3.CO;2-1.View ArticlePubMedGoogle Scholar
  13. Thomas JC, Sebek BA, Krishnamurthi V: Primitive Neuroectodermal tumor of the kidney with inferior cava and atrial tumor thrombus. J Urol. 2002, 168: 1486-1487. 10.1097/00005392-200210010-00045.View ArticlePubMedGoogle Scholar
  14. Weeks DA, Beckwith JB, Mierau GW, Zuppan CW: Renal neoplasms mimicking rhabdoid tumor of kidney. A report from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1991, 15: 1042-54.View ArticlePubMedGoogle Scholar
  15. Reya T, Morrison JS, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature. 2001, 414: 105-111. 10.1038/35102167.View ArticlePubMedGoogle Scholar
  16. Andrews PW: From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci. 1977, 357: 405-417. 10.1098/rstb.2002.1058.View ArticleGoogle Scholar
  17. Novikoff PM, Yam A: Stem cells and rat liver carcinogenesis: contributions of confocal and electron microscopy. J Histochem Cytochem. 1998, 46: 613-626.View ArticlePubMedGoogle Scholar
  18. Pathak S: Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 2002, 22: 1353-1356.PubMedGoogle Scholar
  19. Sell S, Pierce GB: Maturation arrest of stem cell differentiation in a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994, 70: 6-22.PubMedGoogle Scholar
  20. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/4/3/prepub

Copyright

© Pomara et al; licensee BioMed Central Ltd. 2004

This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Advertisement